{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:41:05Z","timestamp":1791358865957,"version":"4.3.1"},"reference-count":252,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s10741-007-9007-4","type":"journal-article","created":{"date-parts":[[2007,3,26]],"date-time":"2007-03-26T19:34:03Z","timestamp":1174937643000},"page":"66-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Cardiac hypertrophy induced by sustained \u03b2-adrenoreceptor activation: pathophysiological aspects"],"prefix":"10.1007","volume":"12","author":[{"given":"Oleg E.","family":"Osadchii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,27]]},"reference":[{"key":"9007_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD et al (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561\u20131566","journal-title":"N Engl J Med"},{"key":"9007_CR2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","volume":"32","author":"AW Haider","year":"1998","unstructured":"Haider AW, Larson MG, Benjamin EJ et al (1998) Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32:1454\u20131459","journal-title":"J Am Coll Cardiol"},{"key":"9007_CR3","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/01.CIR.103.19.2346","volume":"103","author":"J Sundstrom","year":"2001","unstructured":"Sundstrom J, Lind L, Arnlov J et al (2001) Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 103:2346\u20132351","journal-title":"Circulation"},{"key":"9007_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.105.569491","volume":"113","author":"PM Okin","year":"2006","unstructured":"Okin PM, Devereux RB, Nieminen MS et al (2006) Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Circulation 113:67\u201373","journal-title":"Circulation"},{"key":"9007_CR5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","volume":"43","author":"MH Drazner","year":"2004","unstructured":"Drazner MH, Rame JE, Marino EK et al (2004) Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years. J Am Coll Cardiol 43:2207\u20132215","journal-title":"J Am Coll Cardiol"},{"key":"9007_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/CEH-100001199","volume":"23","author":"G Martini","year":"2001","unstructured":"Martini G, Rabbia F, Gastaldi L et al (2001) Heart rate variability and left ventricular diastolic function in patients with borderline hypertension with and without left ventricular hypertrophy. Clin Exp Hypertens 23:77\u201387","journal-title":"Clin Exp Hypertens"},{"key":"9007_CR7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00004872-200207000-00031","volume":"20","author":"S Schafer","year":"2002","unstructured":"Schafer S, Kelm M, Mingers S et al (2002) Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 20:1431\u20131437","journal-title":"J Hypertens"},{"key":"9007_CR8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004872-200302000-00038","volume":"21","author":"C Passino","year":"2003","unstructured":"Passino C, Magagna A, Conforti F et al (2003) Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens 21:445\u2013451","journal-title":"J Hypertens"},{"key":"9007_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","volume":"97","author":"P Verdecchia","year":"1998","unstructured":"Verdecchia P, Schillaci G, Borgioni C et al (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97:48\u201354","journal-title":"Circulation"},{"key":"9007_CR10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E et al (2001) Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104:1615\u20131621","journal-title":"Circulation"},{"key":"9007_CR11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/01.hjh.0000222761.07477.7b","volume":"24","author":"AH Strand","year":"2006","unstructured":"Strand AH, Gudmundsdottir H, Os I et al (2006) Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 24:905\u2013913","journal-title":"J Hypertens"},{"key":"9007_CR12","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(01)01600-X","volume":"38","author":"JP Greenwood","year":"2001","unstructured":"Greenwood JP, Scott EM, Stoker JB et al (2001) Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. J Am Coll Cardiol 38:1711\u20131717","journal-title":"J Am Coll Cardiol"},{"key":"9007_CR13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","volume":"108","author":"MP Schlaich","year":"2003","unstructured":"Schlaich MP, Kaye DM, Lambert E et al (2003) Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108:560\u2013565","journal-title":"Circulation"},{"key":"9007_CR14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00004872-199611000-00015","volume":"14","author":"M Kelm","year":"1996","unstructured":"Kelm M, Schafer S, Mingers S et al (1996) Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14:1365\u20131367","journal-title":"J Hypertens"},{"key":"9007_CR15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/01.hjh.0000166850.80344.cf","volume":"23","author":"MP Schlaich","year":"2005","unstructured":"Schlaich MP, Kaye DM, Lambert E et al (2005) Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens 23:1077\u20131082","journal-title":"J Hypertens"},{"key":"9007_CR16","first-page":"123","volume":"72","author":"CI Chappel","year":"1951","unstructured":"Chappel CI, Rona G, Balazs T et al (1951) Severe myocardial necrosis produced by isoproterenol in the rat. Arch Int Pharmacodyn 72:123\u2013128","journal-title":"Arch Int Pharmacodyn"},{"key":"9007_CR17","first-page":"83","volume":"73","author":"CP Handforth","year":"1962","unstructured":"Handforth CP (1962) Isoproterenol-induced myocardial infarction in animals. Arch Pathol 73:83\u201387","journal-title":"Arch Pathol"},{"key":"9007_CR18","first-page":"27","volume":"50","author":"CA Maruffo","year":"1967","unstructured":"Maruffo CA (1967) Fine structural study of myocardial changes induced by isoproterenol in rhesus monkeys (Macaca mulatta). Am J Pathol 50:27\u201334","journal-title":"Am J Pathol"},{"key":"9007_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0002-8703(68)90163-4","volume":"76","author":"B Ostadal","year":"1968","unstructured":"Ostadal B, Rychterova V, Poupa O (1968) Isoproterenol-induced acute experimental cardiac necrosis in the turtle (Testudo horsfieldi). Am Heart J 76:645\u2013649","journal-title":"Am Heart J"},{"key":"9007_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/geronj\/14.2.169","volume":"14","author":"G Rona","year":"1959","unstructured":"Rona G, Chappel CI, Balazs T et al (1959) The effect of breed, age, and sex on myocardial necrosis produced by isoproterenol in the rat. J Gerontol 14:169\u2013173","journal-title":"J Gerontol"},{"key":"9007_CR21","first-page":"443","volume":"67","author":"G Rona","year":"1959","unstructured":"Rona G, Chappel CI, Balazs T et al (1959) An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67:443\u2013455","journal-title":"Arch Pathol"},{"key":"9007_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-8703(63)90271-0","volume":"66","author":"G Rona","year":"1963","unstructured":"Rona G, Chappel C, Kahn DS (1963) The significance of factors modifying the development of isoproterenol-induced myocardial necrosis. Am Heart J 66:389\u2013395","journal-title":"Am Heart J"},{"key":"9007_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(85)80130-9","volume":"17","author":"G Rona","year":"1985","unstructured":"Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291\u2013306","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR24","first-page":"373","volume":"54","author":"S Bloom","year":"1969","unstructured":"Bloom S, Cancilla PA (1969) Myocytolysis and mitochondrial calcification in rat myocardium after low doses of isoproterenol. Am J Pathol 54:373\u2013381","journal-title":"Am J Pathol"},{"key":"9007_CR25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-8703(69)90131-8","volume":"77","author":"HC Stanton","year":"1969","unstructured":"Stanton HC, Brenner G, Mayfield ED (1969) Studies on isoproterenol-induced cardiomegaly in rats. Am Heart J 77:72\u201380","journal-title":"Am Heart J"},{"key":"9007_CR26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cvr\/9.6.797","volume":"9","author":"P Collins","year":"1975","unstructured":"Collins P, Billings CG, Barer GR et al (1975) Quantitation of isoprenaline-induced changes in the ventricular myocardium. Cardiovasc Res 9:797\u2013806","journal-title":"Cardiovasc Res"},{"key":"9007_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.RES.65.3.657","volume":"65","author":"IJ Benjamin","year":"1989","unstructured":"Benjamin IJ, Jalil JE, Tan LB et al (1989) Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65:657\u2013670","journal-title":"Circ Res"},{"key":"9007_CR28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3181\/00379727-136-35243","volume":"136","author":"EL Alderman","year":"1971","unstructured":"Alderman EL, Harrison DC (1971) Myocardial hypertrophy resulting from low dosage isoproterenol administration in rats. Proc Soc Exp Biol Med 136:268\u2013270","journal-title":"Proc Soc Exp Biol Med"},{"key":"9007_CR29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0022-2828(72)90111-3","volume":"4","author":"AL Gordon","year":"1972","unstructured":"Gordon AL, Inchiosa MA, Lehr D (1972) Isoproterenol-induced cardiomegaly: assessment of myocardial protein content, actomyosin ATPase and heart rate. J Mol Cell Cardiol 4:543\u2013557","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0024-3205(77)90069-8","volume":"21","author":"VT Pagano","year":"1977","unstructured":"Pagano VT, Inchiosa MA (1977) Cardiomegaly produced by chronic beta-adrenergic stimulation in the rat: comparison with alpha-adrenergic effects. Life Sci 21:619\u2013624","journal-title":"Life Sci"},{"key":"9007_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1210\/endo-105-1-246","volume":"105","author":"J Tse","year":"1979","unstructured":"Tse J, Powell JR, Baste CA et al (1979) Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of \u03b2-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology 105:246\u2013255","journal-title":"Endocrinology"},{"key":"9007_CR32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/jappl.1982.52.3.591","volume":"52","author":"KM Baldwin","year":"1982","unstructured":"Baldwin KM, Ernst SB, Mullin WJ et al (1982) Exercise capacity and cardiac function of rats with drug-induced cardiac enlargement. J Appl Physiol 52:591\u2013595","journal-title":"J Appl Physiol"},{"key":"9007_CR33","first-page":"784","volume":"221","author":"HY Chang","year":"1982","unstructured":"Chang HY, Klein RM, Kunos G (1982) Selective desensitization of cardiac beta-adrenoceptors by prolonged in vivo infusion of catecholamines in rats. J Pharmacol Exp Ther 221:784\u2013789","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-2952(82)90181-2","volume":"31","author":"P Chatelain","year":"1982","unstructured":"Chatelain P, Robberecht P, De Neef P et al (1982) Early decrease in secretin-, glucagon-, and isoproterenol-stimulated cardiac adenylate cyclase activity in rats treated with isoproterenol. Biochem Pharmacol 31:347\u2013352","journal-title":"Biochem Pharmacol"},{"key":"9007_CR35","first-page":"411","volume":"220","author":"Y Nomura","year":"1982","unstructured":"Nomura Y, Kajiyama H, Segawa T (1982) Alteration in sensitivity to isoproterenol and acetylcholine in the rat heart after repeated administration of isoproterenol. J Pharmacol Exp Ther 220:411\u2013416","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0020-711X(83)90217-3","volume":"15","author":"K Clarke","year":"1983","unstructured":"Clarke K, Ward LC (1983) Protein synthesis in the early stages of cardiac hypertrophy. Int J Biochem 15:1267\u20131271","journal-title":"Int J Biochem"},{"key":"9007_CR37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1139\/y84-061","volume":"62","author":"PB Taylor","year":"1984","unstructured":"Taylor PB, Tang Q (1984) Development of isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol 62:384\u2013389","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-2952(88)90135-9","volume":"37","author":"P Gengo","year":"1988","unstructured":"Gengo P, Skattebol A, Moran JF et al (1988) Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levels. Biochem Pharmacol 37:627\u2013633","journal-title":"Biochem Pharmacol"},{"key":"9007_CR39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005344-198902000-00004","volume":"13","author":"C Nanoff","year":"1989","unstructured":"Nanoff C, Freissmuth M, Tuisl E et al (1989) A different desensitization pattern of cardiac \u03b2-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J Cardiovasc Pharmacol 13:198\u2013203","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(90)90002-N","volume":"187","author":"N Bowling","year":"1990","unstructured":"Bowling N, Wyss VL, Gengo PJ et al (1990) Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. Eur J Pharmacol 187:155\u2013164","journal-title":"Eur J Pharmacol"},{"key":"9007_CR41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1006\/jmcc.1993.1145","volume":"25","author":"T Brand","year":"1993","unstructured":"Brand T, Sharma HS, Schaper W (1993) Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol 25:1325\u20131337","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR42","first-page":"H1496","volume":"267","author":"E Golomb","year":"1994","unstructured":"Golomb E, Abassi ZA, Cuda G et al (1994) Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol 267:H1496\u20131506","journal-title":"Am J Physiol"},{"key":"9007_CR43","first-page":"H638","volume":"269","author":"MO Boluyt","year":"1995","unstructured":"Boluyt MO, Long X, Eschenhagen T et al (1995) Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol 269:H638\u2013647","journal-title":"Am J Physiol"},{"key":"9007_CR44","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1006\/bbrc.1995.2569","volume":"215","author":"FU Muller","year":"1995","unstructured":"Muller FU, Boknik P, Horst A et al (1995) In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart. Biochem Biophys Res Commun 215:1043\u20131049","journal-title":"Biochem Biophys Res Commun"},{"key":"9007_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1474-8673.1995.tb00308.x","volume":"15","author":"D Sarsero","year":"1995","unstructured":"Sarsero D, Molenaar P (1995) Effects of chronic infusion of (-)-isoprenaline on rat cardiac muscarinic M2-cholinoceptors and \u03b21-and \u03b22-adrenoceptors. J Auton Pharmacol 15:239\u2013255","journal-title":"J Auton Pharmacol"},{"key":"9007_CR46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1536\/ihj.38.849","volume":"38","author":"N Hakamata","year":"1997","unstructured":"Hakamata N, Hamada H, Ohsuzu F et al (1997) Cardiac \u03b2-adrenergic signaling pathway alteration in isoproterenol-induced cardiac hypertrophy in male Sprague-Dawley rats. Jpn Heart J 38:849\u2013857","journal-title":"Jpn Heart J"},{"key":"9007_CR47","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1006\/jmcc.1998.0714","volume":"30","author":"S Masson","year":"1998","unstructured":"Masson S, Arosio B, Luvara G et al (1998) Remodelling of cardiac extracellular matrix during \u03b2-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol 30:1505\u20131514","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00005344-199911000-00003","volume":"34","author":"J Suzuki","year":"1999","unstructured":"Suzuki J, Ohno I, Nawata J et al (1999) Overexpression of insulin-like growth factor-I in hearts of rats with isoproterenol-induced cardiac hypertrophy. J Cardiovasc Pharmacol 34:635\u2013644","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR49","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1006\/jmcc.1999.1033","volume":"31","author":"Y Takemoto","year":"1999","unstructured":"Takemoto Y, Yoshiyama M, Takeuchi K et al (1999) Increased JNK, AP-1 and NF-kB DNA binding activities in isoproterenol-induced cardiac remodelling. J Mol Cell Cardiol 31:2017\u20132030","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/jmcc.2000.1332","volume":"33","author":"C Morisco","year":"2001","unstructured":"Morisco C, Zebrowski DC, Vatner DE et al (2001) \u03b2-adrenergic cardiac hypertrophy is mediated primarily by the \u03b21-subtype in the rat heart. J Mol Cell Cardiol 33:561\u2013573","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-2999(02)02643-2","volume":"456","author":"F Brouri","year":"2002","unstructured":"Brouri F, Findji L, Mediani O et al (2002) Toxic cardiac effects of catecholamines: role of \u03b2-adrenoceptor downregulation. Eur J Pharmacol 456:69\u201375","journal-title":"Eur J Pharmacol"},{"key":"9007_CR52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejphar.2003.11.063","volume":"485","author":"F Brouri","year":"2004","unstructured":"Brouri F, Hanoun N, Mediani O et al (2004) Blockade of \u03b21- and desensitization of \u03b22-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol 485:227\u2013234","journal-title":"Eur J Pharmacol"},{"key":"9007_CR53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00005344-200308000-00004","volume":"42","author":"S Miura","year":"2003","unstructured":"Miura S, Ohno I, Suzuki J et al (2003) Inhibition of matrix metalloproteinases prevents cardiac hypertrophy induced by \u03b2-adrenergic stimulation in rats. J Cardiovasc Pharmacol 42:174\u2013181","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.RES.0000079794.57578.F1","volume":"93","author":"H Tomita","year":"2003","unstructured":"Tomita H, Nazmy M, Kajimoto K et al (2003) Inducible cAMP early repressor is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to \u03b2-adrenergic receptor stimulation. Circ Res 93:12\u201322","journal-title":"Circ Res"},{"key":"9007_CR55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","volume":"65","author":"GX Zhang","year":"2005","unstructured":"Zhang GX, Kimura S, Nishiyama A et al (2005) Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65:230\u2013238","journal-title":"Cardiovasc Res"},{"key":"9007_CR56","first-page":"H590","volume":"262","author":"RJ Robbins","year":"1992","unstructured":"Robbins RJ, Swain JL (1992) C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice. Am J Physiol 262:H590\u2013597","journal-title":"Am J Physiol"},{"key":"9007_CR57","first-page":"H1439","volume":"266","author":"MH Soonpaa","year":"1994","unstructured":"Soonpaa MH, Field LJ (1994) Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 266:H1439\u20131445","journal-title":"Am J Physiol"},{"key":"9007_CR58","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1006\/jmcc.1997.0508","volume":"29","author":"RK Kudej","year":"1997","unstructured":"Kudej RK, Iwase M, Uechi M et al (1997) Effects of chronic \u03b2-adrenergic receptor stimulation in mice. J Mol Cell Cardiol 29:2735\u20132746","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR59","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.98.17.1783","volume":"98","author":"G Iaccarino","year":"1998","unstructured":"Iaccarino G, Tomhave ED, Lefkowitz RJ et al (1998) Reciprocal in vivo regulation of myocardial G-protein-coupled receptor kinase expression by \u03b2-adrenergic receptor stimulation and blockade. Circulation 98:1783\u20131789","journal-title":"Circulation"},{"key":"9007_CR60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.HYP.33.1.396","volume":"33","author":"G Iaccarino","year":"1999","unstructured":"Iaccarino G, Dolber PC, Lefkowitz RJ et al (1999) \u03b2-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy. Hypertension 33:396\u2013401","journal-title":"Hypertension"},{"key":"9007_CR61","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.bjp.0702676","volume":"127","author":"N Saadane","year":"1999","unstructured":"Saadane N, Alpert L, Chalifour LE (1999) Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol 127:1165\u20131176","journal-title":"Br J Pharmacol"},{"key":"9007_CR62","first-page":"H796","volume":"278","author":"N Saadane","year":"2000","unstructured":"Saadane N, Alpert L, Chalifour LE (2000) Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in EGR-1 deficient mice. Am J Physiol 278:H796\u2013805","journal-title":"Am J Physiol"},{"key":"9007_CR63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/hc2601.090987","volume":"104","author":"Y Zou","year":"2001","unstructured":"Zou Y, Yao A, Zhu W et al (2001) Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 104:102\u2013108","journal-title":"Circulation"},{"key":"9007_CR64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1253\/circj.66.851","volume":"66","author":"M Ozaki","year":"2002","unstructured":"Ozaki M, Kawashima S, Yamashita T et al (2002) Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 66:851\u2013856","journal-title":"Circ J"},{"key":"9007_CR65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1022808224917","volume":"245","author":"A Chattopadhyay","year":"2003","unstructured":"Chattopadhyay A, Biswas S, Bandyopadhyay D et al (2003) Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol Cell Biochem 245:43\u201349","journal-title":"Mol Cell Biochem"},{"key":"9007_CR66","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1161\/01.CIR.0000091403.62293.2B","volume":"108","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Crackower MA, Eriksson U et al (2003) Phosphoinositide 3-kinase \u03b3-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108:2147\u20132152","journal-title":"Circulation"},{"key":"9007_CR67","doi-asserted-by":"crossref","first-page":"21070","DOI":"10.1074\/jbc.M211028200","volume":"278","author":"F Yin","year":"2003","unstructured":"Yin F, Li P, Zheng M et al (2003) Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart. J Biol Chem 278:21070\u201321075","journal-title":"J Biol Chem"},{"key":"9007_CR68","doi-asserted-by":"crossref","first-page":"47694","DOI":"10.1074\/jbc.M309661200","volume":"278","author":"A Zahabi","year":"2003","unstructured":"Zahabi A, Picard S, Fortin N et al (2003) Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. J Biol Chem 278:47694\u201347699","journal-title":"J Biol Chem"},{"key":"9007_CR69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1139\/y03-134","volume":"82","author":"S Dostanic","year":"2004","unstructured":"Dostanic S, Servant N, Wang C et al (2004) Chronic \u03b2-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart. Can J Physiol Pharmacol 82:167\u2013174","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.autneu.2004.07.003","volume":"114","author":"AL Gava","year":"2004","unstructured":"Gava AL, Peotta VA, Cabral AM et al (2004) Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy. Auton Neurosci 114:47\u201354","journal-title":"Auton Neurosci"},{"key":"9007_CR71","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","volume":"110","author":"F Jaffre","year":"2004","unstructured":"Jaffre F, Callebert J, Sarre A et al (2004) Involvement of the serotonin 5-HT2b receptor in cardiac hypertrophy linked to sympathetic stimulation. Circulation 110:969\u2013974","journal-title":"Circulation"},{"key":"9007_CR72","first-page":"H30","volume":"289","author":"MD Faulx","year":"2005","unstructured":"Faulx MD, Ernsberger P, Vatner D et al (2005) Strain dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol 289:H30\u201336","journal-title":"Am J Physiol"},{"key":"9007_CR73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y04-137","volume":"83","author":"AR Hohimer","year":"2005","unstructured":"Hohimer AR, Davis LE, Hatton DC (2005) Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol 83:191\u2013197","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.CIR.80.3.669","volume":"80","author":"AS Maisel","year":"1989","unstructured":"Maisel AS, Phillips C, Michel MC et al (1989) Regulation of cardiac \u03b2-adrenergic receptors by captopril. Implications for congestive heart failure. Circulation 80:669\u2013675","journal-title":"Circulation"},{"key":"9007_CR75","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00005344-199606000-00021","volume":"27","author":"AM Gillis","year":"1996","unstructured":"Gillis AM, Mathison HJ, Patel C et al (1996) Quinidine pharmacodynamics in normal and isoproterenol-induced hypertrophied blood-perfused working rabbit hearts. J Cardiovasc Pharmacol 27:916\u2013926","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR76","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbamcr.2006.08.002","volume":"1763","author":"N Kim","year":"2006","unstructured":"Kim N, Kim H, Youm JB et al (2006) Site specific differential activation of ras\/raf\/ERK signaling in rabbit isoproterenol-induced left ventricular hypertrophy. Biochim Biophys Acta 1763:1067\u20131075","journal-title":"Biochim Biophys Acta"},{"key":"9007_CR77","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0024-3205(70)90281-X","volume":"9","author":"JH Gans","year":"1970","unstructured":"Gans JH, Cater MR (1970) Norepinephrine-induced cardiac hypertrophy in dogs. Life Sci 9:731\u2013740","journal-title":"Life Sci"},{"key":"9007_CR78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.64.1.75","volume":"64","author":"MM Laks","year":"1973","unstructured":"Laks MM, Morady F, Swan HJC (1973) Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 64:75\u201378","journal-title":"Chest"},{"key":"9007_CR79","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/01.HYP.9.6.582","volume":"9","author":"BD King","year":"1987","unstructured":"King BD, Sack D, Kichuk MR et al (1987) Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs. Hypertension 9:582\u2013590","journal-title":"Hypertension"},{"key":"9007_CR80","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.84.5.2091","volume":"84","author":"MB Patel","year":"1991","unstructured":"Patel MB, Stewart JM, Loud AV et al (1991) Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 84:2091\u20132100","journal-title":"Circulation"},{"key":"9007_CR81","first-page":"H331","volume":"262","author":"JM Stewart","year":"1992","unstructured":"Stewart JM, Patel MB, Wang J et al (1992) Chronic elevation of norepinephrine in conscious dogs produces hypertrophy with no loss of LV reserve. Am J Physiol 262:H331\u2013339","journal-title":"Am J Physiol"},{"key":"9007_CR82","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1073\/pnas.88.6.2132","volume":"88","author":"NH Bishopric","year":"1991","unstructured":"Bishopric NH, Kedes L (1991) Adrenergic regulation of the skeletal \u03b1-actin gene promoter during myocardial cell hypertrophy. Proc Natl Acad Sci USA 88:2132\u20132136","journal-title":"Proc Natl Acad Sci USA"},{"key":"9007_CR83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj3140115","volume":"314","author":"MA Bogoyevitch","year":"1996","unstructured":"Bogoyevitch MA, Andersson MB, Gillespie-Brown J et al (1996) Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314:115\u2013121","journal-title":"Biochem J"},{"key":"9007_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1600-0773.1986.tb00080.x","volume":"58","author":"AB Jeppsson","year":"1986","unstructured":"Jeppsson AB, Waldeck B, Widmark E (1986) Further studies on the cardiomegaly induced by \u03b2-adrenoceptor agonists. Acta Pharmacol Toxicol 58:121\u2013125","journal-title":"Acta Pharmacol Toxicol"},{"key":"9007_CR85","doi-asserted-by":"crossref","first-page":"C495","DOI":"10.1152\/ajpcell.2000.279.2.C495","volume":"279","author":"M Schafer","year":"2000","unstructured":"Schafer M, Frischkopf K, Taimor G et al (2000) Hypertrophic effect of selective \u03b21-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol 279:C495\u2013503","journal-title":"Am J Physiol"},{"key":"9007_CR86","first-page":"H329","volume":"265","author":"RS Decker","year":"1993","unstructured":"Decker RS, Cook MG, Behnke-Barclay MM et al (1993) Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes. Am J Physiol 265:H329\u2013339","journal-title":"Am J Physiol"},{"key":"9007_CR87","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/jmcc.1993.1053","volume":"25","author":"A Pinson","year":"1993","unstructured":"Pinson A, Schluter KD, Zhou XJ et al (1993) Alpha- and beta-adrenergic stimulation of protein synthesis in cultured adult cardiomyocytes. J Mol Cell Cardiol 25:477\u2013490","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR88","doi-asserted-by":"crossref","first-page":"C1311","DOI":"10.1152\/ajpcell.1995.269.5.C1311","volume":"269","author":"KD Schluter","year":"1995","unstructured":"Schluter KD, Zhou XJ, Piper HM (1995) Induction of hypertrophic responsiveness to isoproterenol by TGF-\u03b21 in adult rat cardiomyocytes. Am J Physiol 269:C1311\u20131316","journal-title":"Am J Physiol"},{"key":"9007_CR89","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/01.CIR.95.5.1260","volume":"95","author":"T Yamazaki","year":"1997","unstructured":"Yamazaki T, Komuro I, Zou Y et al (1997) Norepinephrine induces the raf-1 kinase\/mitogen-activated protein kinase cascade through both \u03b11-and \u03b2-adrenoceptors. Circulation 95:1260\u20131268","journal-title":"Circulation"},{"key":"9007_CR90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0008-6363(98)00171-0","volume":"40","author":"KD Schluter","year":"1998","unstructured":"Schluter KD, Goldberg Y, Taimor G et al (1998) Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes. Cardiovasc Res 40:174\u2013181","journal-title":"Cardiovasc Res"},{"key":"9007_CR91","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/jmcc.2000.1135","volume":"32","author":"T Ueyama","year":"2000","unstructured":"Ueyama T, Kawashima S, Sakoda T et al (2000) Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol 32:947\u2013960","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0703792","volume":"132","author":"JD Luo","year":"2001","unstructured":"Luo JD, Xie F, Zhang WW et al (2001) Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyoytes. Br J Pharmacol 132:159\u2013164","journal-title":"Br J Pharmacol"},{"key":"9007_CR93","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1139\/y82-207","volume":"60","author":"PK Singal","year":"1982","unstructured":"Singal PK, Kapur N, Dhillon KS et al (1982) Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 60:1390\u20131397","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.75.1.105","volume":"75","author":"JR Teerlink","year":"1994","unstructured":"Teerlink JR, Pfeffer JM, Pfeffer MA (1994) Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75:105\u2013113","journal-title":"Circ Res"},{"key":"9007_CR95","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-5273(02)00369-8","volume":"86","author":"Y Ng","year":"2002","unstructured":"Ng Y, Goldspink DF, Burniston JG et al (2002) Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol 86:299\u2013309","journal-title":"Int J Cardiol"},{"key":"9007_CR96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1113\/expphysiol.2004.027482","volume":"89","author":"DF Goldspink","year":"2004","unstructured":"Goldspink DF, Burniston JG, Ellison GM et al (2004) Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol 89:407\u2013416","journal-title":"Exp Physiol"},{"key":"9007_CR97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.fjc.0000141474.06383.6f","volume":"44","author":"Z Li","year":"2004","unstructured":"Li Z, Tran TT, Ma JY et al (2004) p38\u03b1 mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 44:486\u2013492","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR98","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1113\/expphysiol.2005.032615","volume":"91","author":"D Meng","year":"2006","unstructured":"Meng D, Feng L, Chen XJ et al (2006) Trimetazidine improved Ca2+ handling in isoprenaline-mediated myocardial injury of rats. Exp Physiol 91:591\u2013601","journal-title":"Exp Physiol"},{"key":"9007_CR99","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.64.6.1041","volume":"64","author":"JE Jalil","year":"1989","unstructured":"Jalil JE, Doering CW, Janicki JS et al (1989) Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64:1041\u20131050","journal-title":"Circ Res"},{"key":"9007_CR100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.RES.65.2.258","volume":"65","author":"JE Jalil","year":"1989","unstructured":"Jalil JE, Janicki JS, Pick R et al (1989) Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res 65:258\u2013264","journal-title":"Circ Res"},{"key":"9007_CR101","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0022-2828(90)90077-F","volume":"22","author":"MF Allard","year":"1990","unstructured":"Allard MF, De Venny MF, Doss LK et al (1990) Alterations in dietary sodium affect isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol 22:1135\u20131145","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR102","first-page":"1131","volume":"139","author":"B Bhambi","year":"1991","unstructured":"Bhambi B, Eghbali M (1991) Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. Am J Pathol 139:1131\u20131142","journal-title":"Am J Pathol"},{"key":"9007_CR103","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/cvr\/28.12.1835","volume":"28","author":"T Omura","year":"1994","unstructured":"Omura T, Kim S, Takeuchi K et al (1994) Transforming growth factor \u03b21 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system. Cardiovasc Res 28:1835\u20131842","journal-title":"Cardiovasc Res"},{"key":"9007_CR104","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","volume":"37","author":"D Grimm","year":"1998","unstructured":"Grimm D, Elsner D, Schunkert H et al (1998) Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37:91\u2013100","journal-title":"Cardiovasc Res"},{"key":"9007_CR105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1054-8807(99)00021-6","volume":"8","author":"D Grimm","year":"1999","unstructured":"Grimm D, Holmer SR, Riegger GAJ et al (1999) Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat. Cardiovasc Pathol 8:315\u2013323","journal-title":"Cardiovasc Pathol"},{"key":"9007_CR106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1253\/jcj.62.47","volume":"62","author":"M Yoshiyama","year":"1998","unstructured":"Yoshiyama M, Takeuchi K, Kim S et al (1998) Effect of manidipine hydrochloride, a calcium antagonist, on isoproterenol-induced left ventricular hypertrophy. Jpn Circ J 62:47\u201352","journal-title":"Jpn Circ J"},{"key":"9007_CR107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/jmcc.1999.1075","volume":"32","author":"W Barth","year":"2000","unstructured":"Barth W, Deten A, Bauer M et al (2000) Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 32:273\u2013284","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/phrs.2001.0865","volume":"44","author":"M Gallego","year":"2001","unstructured":"Gallego M, Espina L, Vegas L et al (2001) Spironolactone and captopril attenuates isoproterenol-induced cardiac remodeling in rats. Pharmacol Res 44:311\u2013315","journal-title":"Pharmacol Res"},{"key":"9007_CR109","first-page":"H2410","volume":"281","author":"FHH Leenen","year":"2001","unstructured":"Leenen FHH, White R, Yuan B (2001) Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol 281:H2410\u20132416","journal-title":"Am J Physiol"},{"key":"9007_CR110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005344-200208000-00010","volume":"40","author":"MP Ocaranza","year":"2002","unstructured":"Ocaranza MP, Diaz-Araya G, Chiong M et al (2002) Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis. J Cardiovasc Pharmacol 40:246\u2013254","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR111","first-page":"H961","volume":"275","author":"Y Shizukuda","year":"1998","unstructured":"Shizukuda Y, Buttrick PM, Geenen DL et al (1998) \u03b2-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 275:H961\u2013968","journal-title":"Am J Physiol"},{"key":"9007_CR112","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-2828(86)80938-5","volume":"18","author":"ME Upsher","year":"1986","unstructured":"Upsher ME, Weiss HR (1986) Heterogeneous distribution of beta-adrenoceptors in the dog left ventricle. J Mol Cell Cardiol 18:657\u2013660","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR113","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/cvr\/27.2.192","volume":"27","author":"H Mori","year":"1993","unstructured":"Mori H, Ishikawa S, Kojima S et al (1993) Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res 27:192\u2013198","journal-title":"Cardiovasc Res"},{"key":"9007_CR114","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.0000071180.12012.6E","volume":"41","author":"IL Ennis","year":"2003","unstructured":"Ennis IL, Escudero EM, Console GM et al (2003) Regression of isoproterenol-induced cardiac hypertrophy by Na+\/H+ exchanger inhibition. Hypertension 41:1324\u20131329","journal-title":"Hypertension"},{"key":"9007_CR115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(95)00781-K","volume":"694","author":"CE Gianuzzi","year":"1995","unstructured":"Gianuzzi CE, Seidler FJ, Slotkin TA (1995) \u03b2-adrenoceptor control of cardiac adenylyl cyclase during development: agonist pre-treatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 694:271\u2013278","journal-title":"Brain Res"},{"key":"9007_CR116","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1006\/jmcc.1996.0303","volume":"29","author":"JL Zeiders","year":"1997","unstructured":"Zeiders JL, Seidler FJ, Slotkin TA (1997) Ontogeny of regulatory mechanisms for \u03b2-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol 29:603\u2013615","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jmcc.1998.0875","volume":"31","author":"JL Zeiders","year":"1999","unstructured":"Zeiders JL, Seidler FJ, Iaccarino G et al (1999) Ontogeny of cardiac \u03b2-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor\/G-protein transduction rather than eliciting uncoupling. J Mol Cell Cardiol 31:413\u2013423","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR118","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1440-1681.2000.03254.x","volume":"27","author":"N Murad","year":"2000","unstructured":"Murad N, Tucci PJF (2000) Isoproterenol-induced hypertrophy may result in distinct left ventricular changes. Clin Exp Pharmacol Physiol 27:352\u2013357","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9007_CR119","first-page":"365","volume":"134","author":"R Pick","year":"1989","unstructured":"Pick R, Jalil JE, Janicki J et al (1989) The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol 134:365\u2013371","journal-title":"Am J Pathol"},{"key":"9007_CR120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1139\/y84-191","volume":"62","author":"Q Tang","year":"1984","unstructured":"Tang Q, Taylor PB (1984) Regression of isoproterenol-induced cardiac hypertrophy. Can J Physiol Pharmacol 62:1141\u20131146","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR121","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1139\/y81-020","volume":"59","author":"Y Deshaies","year":"1981","unstructured":"Deshaies Y, Willemot J, Leblanc J (1981) Protein synthesis, amino acid uptake, and pools during isoproterenol-induced hypertrophy of the rat heart and tibialis muscle. Can J Physiol Pharmacol 59:113\u2013121","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR122","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.RES.66.3.867","volume":"66","author":"I Dubus","year":"1990","unstructured":"Dubus I, Samuel JL, Marotte F et al (1990) \u03b2-adrenergic agonists stimulate the synthesis of noncontractile but not contractile proteins in cultured myocytes isolated from adult rat heart. Circ Res 66:867\u2013874","journal-title":"Circ Res"},{"key":"9007_CR123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0008-6363(99)00351-X","volume":"45","author":"KD Schluter","year":"2000","unstructured":"Schluter KD, Frischkopf K, Flesch M et al (2000) Central role for ornithine decarboxylase in \u03b2-adrenoceptor-mediated hypertrophy. Cardiovasc Res 45:410\u2013417","journal-title":"Cardiovasc Res"},{"key":"9007_CR124","first-page":"482","volume":"187","author":"S Mallov","year":"1973","unstructured":"Mallov S (1973) Effect of sympathomimetic drugs on protein synthesis in rat heart. J Pharmacol Exp Ther 187:482\u2013494","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-2828(71)90011-3","volume":"3","author":"WG Wood","year":"1971","unstructured":"Wood WG, Lindenmayer GE, Schwartz A (1971) Myocardial synthesis of ribonucleic acid. I. Stimulation by isoproterenol. J Mol Cell Cardiol 3:127\u2013138","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR126","first-page":"311","volume":"3","author":"Q Tang","year":"1987","unstructured":"Tang Q, Taylor PB, Helbing RK (1987) Catecholamine-induced cardiac hypertrophy. Can J Cardiol 3:311\u2013316","journal-title":"Can J Cardiol"},{"key":"9007_CR127","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.6449079","volume":"210","author":"J Bartolome","year":"1980","unstructured":"Bartolome J, Huguenard J, Slotkin TA (1980) Role of ornithine decarboxylase in cardiac growth and hypertrophy. Science 210:793\u2013794","journal-title":"Science"},{"key":"9007_CR128","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/0024-3205(85)90144-4","volume":"36","author":"DF Larson","year":"1985","unstructured":"Larson DF, Copeland JG, Russell DH (1985) Catecholamine-induced cardiac hypertrophy in a denervated, hemodynamically non-stressed heart transplant. Life Sci 36:2477\u20132489","journal-title":"Life Sci"},{"key":"9007_CR129","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0006-2952(76)90477-9","volume":"25","author":"S Mallov","year":"1975","unstructured":"Mallov S (1975) Effect of sympathomimetic amines and monoamine oxidase inhibitors on protein synthesis in rat heart. Biochem Pharmacol 25:1645\u20131651","journal-title":"Biochem Pharmacol"},{"key":"9007_CR130","doi-asserted-by":"crossref","first-page":"C530","DOI":"10.1152\/ajpcell.1991.261.3.C530","volume":"261","author":"WA Clark","year":"1991","unstructured":"Clark WA, Rudnick SJ, LaPres JJ et al (1991) Hypertrophy of isolated adult feline heart cells following \u03b2-adrenergic-induced beating. Am J Physiol 261:C530\u2013542","journal-title":"Am J Physiol"},{"key":"9007_CR131","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0008-6363(95)00188-3","volume":"31","author":"M Irlbeck","year":"1996","unstructured":"Irlbeck M, Muhling O, Iwai T et al (1996) Different response of the rat left and right heart to norepinephrine. Cardiovasc Res 31:157\u2013162","journal-title":"Cardiovasc Res"},{"key":"9007_CR132","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1248\/bpb.27.1130","volume":"27","author":"K Kizaki","year":"2004","unstructured":"Kizaki K, Momozaki M, Akatsuka K et al (2004) Impaired gene expression of \u03b21-adrenergic receptor, but not stimulatory G-protein Gs\u03b1, in rat ventricular myocardium treated with isoproterenol. Biol Pharm Bull 27:1130\u20131132","journal-title":"Biol Pharm Bull"},{"key":"9007_CR133","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.lfs.2005.04.047","volume":"78","author":"O Osadchii","year":"2005","unstructured":"Osadchii O, Woodiwiss A, Alves N et al (2005) Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation. Life Sci 78:366\u2013375","journal-title":"Life Sci"},{"key":"9007_CR134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00424-005-0025-6","volume":"452","author":"O Osadchii","year":"2006","unstructured":"Osadchii O, Woodiwiss A, Norton G (2006) Contractile responses to selective phosphodiesterase inhibitors following chronic \u03b2-adrenoreceptor activation. Pflugers Arch 452:155\u2013163","journal-title":"Pflugers Arch"},{"key":"9007_CR135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-2999(96)00805-9","volume":"318","author":"L Tang","year":"1996","unstructured":"Tang L, Gao W, Taylor PB (1996) Force-frequency response in isoproterenol-induced hypertrophied rat heart. Eur J Pharmacol 318:349\u2013356","journal-title":"Eur J Pharmacol"},{"key":"9007_CR136","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00004872-199606000-00011","volume":"14","author":"L Tang","year":"1996","unstructured":"Tang L, Taylor PB (1996) Altered contractile function in isoproterenol-induced hypertrophied rat heart. J Hypertens 14:751\u2013757","journal-title":"J Hypertens"},{"key":"9007_CR137","first-page":"213","volume":"6","author":"YC Lin","year":"1973","unstructured":"Lin YC (1973) Hemodynamics in the rat with isoproterenol-induced cardiac hypertrophy. Res Commun Chem Pathol Pharmacol 6:213\u2013220","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"9007_CR138","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.lfs.2006.02.029","volume":"78","author":"M Ishizawa","year":"2006","unstructured":"Ishizawa M, Mizushige K, Noma T et al (2006) An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic \u03b2-adrenergic stimulation rat model. Life Sci 78:2974\u20132982","journal-title":"Life Sci"},{"key":"9007_CR139","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/y99-136","volume":"78","author":"S Lahlou","year":"2000","unstructured":"Lahlou S, Lima GC, Leao-Filho CSC et al (2000) Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats. Can J Physiol Pharmacol 78:260\u2013265","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR140","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.yjmcc.2005.07.017","volume":"39","author":"AP McQueen","year":"2005","unstructured":"McQueen AP, Zhang D, Hu P et al (2005) Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. J Mol Cell Cardiol 39:882\u2013892","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(92)90422-Z","volume":"210","author":"J Meszaros","year":"1992","unstructured":"Meszaros J (1992) Sodium-pump injury and arrhythmogenic transient depolarizations in catecholamine-induced cardiac hypertrophy. Eur J Pharmacol 210:325\u2013331","journal-title":"Eur J Pharmacol"},{"key":"9007_CR142","first-page":"H903","volume":"281","author":"J Meszaros","year":"2001","unstructured":"Meszaros J, Khananshvili D, Hart G (2001) Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol 281:H903\u2013914","journal-title":"Am J Physiol"},{"key":"9007_CR143","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cardiores.2003.11.019","volume":"61","author":"A Chorvatova","year":"2004","unstructured":"Chorvatova A, Hart G, Hussain M (2004) Na+\/Ca2+ exchange current (I Na\/Ca) and sarcoplasmic reticulum Ca2+ release in catecholamine-induced cardiac hypertrophy. Cardiovasc Res 61:278\u2013287","journal-title":"Cardiovasc Res"},{"key":"9007_CR144","first-page":"633","volume":"231","author":"JS Hayes","year":"1984","unstructured":"Hayes JS, Pollock GD, Fuller RW (1984) In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. J Pharmacol Exp Ther 231:633\u2013639","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00005344-199010000-00009","volume":"16","author":"W Vleeming","year":"1990","unstructured":"Vleeming W, van Rooij HH, Wemer J et al (1990) Modulation of adrenoceptor-mediated cardiovascular effects by short-term in vivo infusion of isoproterenol in rats. J Cardiovasc Pharmacol 16:584\u2013593","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR146","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1476-5381.1993.tb12857.x","volume":"108","author":"MC Butterfield","year":"1993","unstructured":"Butterfield MC, Chess-Williams R (1993) Potentiation of \u03b1-adrenoceptor-mediated responses following chronic \u03b2-adrenoceptor stimulation in the rat heart. Br J Pharmacol 108:658\u2013662","journal-title":"Br J Pharmacol"},{"key":"9007_CR147","first-page":"H2021","volume":"270","author":"B Stein","year":"1996","unstructured":"Stein B, Bartel S, Kirchhefer U et al (1996) Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. Am J Physiol 270:H2021\u20132028","journal-title":"Am J Physiol"},{"key":"9007_CR148","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3565(24)37614-1","volume":"286","author":"B Linck","year":"1998","unstructured":"Linck B, Boknik P, Baba HA et al (1998) Long-term beta-adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. J Pharmacol Exp Ther 286:531\u2013538","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR149","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.103.1.155","volume":"103","author":"AJ Woodiwiss","year":"2001","unstructured":"Woodiwiss AJ, Tsotetsi OJ, Sprott S et al (2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103:155\u2013160","journal-title":"Circulation"},{"key":"9007_CR150","first-page":"H277","volume":"287","author":"Y Kitagawa","year":"2004","unstructured":"Kitagawa Y, Yamashita D, Ito H et al (2004) Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts. Am J Physiol 287:H277\u2013285","journal-title":"Am J Physiol"},{"key":"9007_CR151","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000164567.62172.c5","volume":"45","author":"DG Veliotes","year":"2005","unstructured":"Veliotes DG, Woodiwiss AJ, Deftereos DA et al (2005) Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by \u03b2-adrenoreceptor activation. Hypertension 45:914\u2013920","journal-title":"Hypertension"},{"key":"9007_CR152","doi-asserted-by":"crossref","unstructured":"Osadchii OE, Norton GR, McKechnie R et al (2007) Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic \u03b2-adrenoreceptor activation. Am J Physiol (in press). doi:10.1152\/ajpheart.00740.2006","DOI":"10.1152\/ajpheart.00740.2006"},{"key":"9007_CR153","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002100000283","volume":"362","author":"P Boknik","year":"2000","unstructured":"Boknik P, Fockenbrock M, Herzig S et al (2000) Protein phosphatase activity is increased in a rat model of long-term \u03b2-adrenergic stimulation. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 362:222\u2013231","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR154","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/abbi.2000.2234","volume":"387","author":"PS Tappia","year":"2001","unstructured":"Tappia PS, Hata T, Hozaima L et al (2001) Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys 387:85\u201392","journal-title":"Arch Biochem Biophys"},{"key":"9007_CR155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-1838(98)00129-5","volume":"73","author":"SS Meyrelles","year":"1998","unstructured":"Meyrelles SS, Mauad H, Mathias SC et al (1998) Effects of myocardial hypertrophy on neural reflexes controlling cardiovascular function. J Auton Nerv Syst 73:135\u2013142","journal-title":"J Auton Nerv Syst"},{"key":"9007_CR156","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00168760","volume":"353","author":"JM Matthews","year":"1996","unstructured":"Matthews JM, Falckh PHJ, Molenaar P et al (1996) Chronic (-)-isoprenaline infusion down-regulates \u03b21- and \u03b22-adrenoreceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 353:213\u2013225","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR157","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/01.RES.23.6.771","volume":"23","author":"RA Mueller","year":"1968","unstructured":"Mueller RA, Axelrod J (1968) Abnormal cardiac norepinephrine storage in isoproterenol-treated rats. Circ Res 23:771\u2013778","journal-title":"Circ Res"},{"key":"9007_CR158","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/cvr\/5.3.364","volume":"5","author":"RA Mueller","year":"1971","unstructured":"Mueller RA, Thoenen H (1971) Cardiac catecholamine synthesis, turnover and metabolism with isoproterenol-induced myocytolisis. Cardiovasc Res 5:364\u2013370","journal-title":"Cardiovasc Res"},{"key":"9007_CR159","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1139\/y71-033","volume":"49","author":"NS Dhalla","year":"1971","unstructured":"Dhalla NS, Balasubramanian V, Goldman J (1971) Biochemical basis of heart function, III. Influence of isoproterenol on the norepinephrine stores in the rat heart. Can J Physiol Pharmacol 49:302\u2013311","journal-title":"Can J Physiol Pharmacol"},{"key":"9007_CR160","first-page":"H31","volume":"246","author":"WJ Raum","year":"1984","unstructured":"Raum WJ, Laks MM, Garner D et al (1984) Norepinephrine increases \u03b2-receptors and adenylate cyclase in canine myocardium. Am J Physiol 246:H31\u201336","journal-title":"Am J Physiol"},{"key":"9007_CR161","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.88.3.1299","volume":"88","author":"Y Himura","year":"1993","unstructured":"Himura Y, Felten SY, Kashiki M et al (1993) Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88:1299\u20131309","journal-title":"Circulation"},{"key":"9007_CR162","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(99)00652-4","volume":"384","author":"DE Dong","year":"1999","unstructured":"Dong DE, Yatani A, Mohan A et al (1999) Myocardial \u03b2-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity. Eur J Pharmacol 384:17\u201324","journal-title":"Eur J Pharmacol"},{"key":"9007_CR163","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(96)00311-1","volume":"309","author":"LP Lai","year":"1996","unstructured":"Lai LP, Fan THM, Delehanty JM et al (1996) Elevated myocardial interstitial norepinephrine concentration contributes to the regulation of Na+, K+-ATPase in heart failure. Eur J Pharmacol 309:235\u2013241","journal-title":"Eur J Pharmacol"},{"key":"9007_CR164","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0014-2999(92)90423-2","volume":"210","author":"J Meszaros","year":"1992","unstructured":"Meszaros J, Levai G (1992) Catecholamine-induced cardiac hypertrophy uncouples \u03b2-adrenoceptors from slow calcium channels. Eur J Pharmacol 210:333\u2013338","journal-title":"Eur J Pharmacol"},{"key":"9007_CR165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1113\/expphysiol.1997.sp004016","volume":"82","author":"J Meszaros","year":"1997","unstructured":"Meszaros J, Coutihno JJ, Bryant SM et al (1997) L-type calcium current in catecholamine-induced cardiac hypertrophy in the rat. Exp Physiol 82:71\u201383","journal-title":"Exp Physiol"},{"key":"9007_CR166","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0008-6363(99)00033-4","volume":"42","author":"SM Bryant","year":"1999","unstructured":"Bryant SM, Shipsey SJ, Hart G (1999) Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy. Cardiovasc Res 42:391\u2013401","journal-title":"Cardiovasc Res"},{"key":"9007_CR167","first-page":"H2360","volume":"271","author":"J Meszaros","year":"1996","unstructured":"Meszaros J, Ryder K, Hart G (1996) Transient outward current in catecholamine-induced cardiac hypertrophy in the rat. Am J Physiol 271:H2360\u20132367","journal-title":"Am J Physiol"},{"key":"9007_CR168","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.89.1.313","volume":"89","author":"CH Kim","year":"1994","unstructured":"Kim CH, Fan THM, Kelly PF et al (1994) Isoform-specific regulation of myocardial Na,K-ATPase \u03b1-subunit in congestive heart failure. Circulation 89:313\u2013320","journal-title":"Circulation"},{"key":"9007_CR169","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/jpet.104.078345","volume":"313","author":"M Baek","year":"2005","unstructured":"Baek M, Weiss M (2005) Down-regulation of Na+ pump \u03b12 isoform in isoprenaline-induced cardiac hypertrophy in rat: evidence for increased receptor binding affinity but reduced inotropic potency of digoxin. J Pharmacol Exp Ther 313:731\u2013739","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI114357","volume":"84","author":"DE Vatner","year":"1989","unstructured":"Vatner DE, Vatner SF, Nejima J et al (1989) Chronic norepinephrine elicits desensitization by uncoupling the \u03b2-receptor. J Clin Invest 84:1741\u20131748","journal-title":"J Clin Invest"},{"key":"9007_CR171","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1474-8673.1996.tb00361.x","volume":"16","author":"DHT Chang","year":"1996","unstructured":"Chang DHT, Einstein R (1996) Changes in cardiovascular responsiveness to dopexamine and \u03b21- and \u03b22-adrenoceptor function after the chronic treatment of \u03b2-adrenoceptor antagonists and agonists in anaesthetized dogs. J Auton Pharmacol 16:269\u2013279","journal-title":"J Auton Pharmacol"},{"key":"9007_CR172","first-page":"757","volume":"237","author":"JS Hayes","year":"1986","unstructured":"Hayes JS, Wyss VL, Schenck KS et al (1986) Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists. J Pharmacol Exp Ther 237:757\u2013763","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR173","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1994.tb13116.x","volume":"112","author":"SW Martin","year":"1994","unstructured":"Martin SW, Broadley KJ (1994) Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, \u03b21-and \u03b22-receptor-mediated responses. Br J Pharmacol 112:595\u2013603","journal-title":"Br J Pharmacol"},{"key":"9007_CR174","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00169134","volume":"349","author":"FD Russell","year":"1994","unstructured":"Russell FD, Kompa AR, Molenaar P et al (1994) Regulation of \u03b2-adrenoceptors in the guinea-pig sinoatrial node. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 349:463\u2013472","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00499230","volume":"293","author":"AJ Kaumann","year":"1976","unstructured":"Kaumann AJ, Birnbaumer L (1976) Desensitization of kitten atria to chronotropic, inotropic and adenylyl cyclase stimulating effects of (-) isoprenaline. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 293:199\u2013202","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR176","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00495952","volume":"325","author":"A Hedberg","year":"1984","unstructured":"Hedberg A, Mattsson H, Nerme V et al (1984) Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 325:251\u2013258","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR177","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00005344-199208000-00019","volume":"20","author":"L Brown","year":"1992","unstructured":"Brown L, Sernia C, Newling R et al (1992) Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. J Cardiovasc Pharmacol 20:316\u2013323","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR178","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00005344-199510000-00012","volume":"26","author":"SK Laycock","year":"1995","unstructured":"Laycock SK, McMurray J, Kane KA et al (1995) Effects of chronic norepinephrine administration on cardiac function in rats. J Cardiovasc Pharmacol 26:584\u2013589","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR179","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.RES.47.4.493","volume":"47","author":"JD Marsh","year":"1980","unstructured":"Marsh JD, Barry WH, Neer EJ et al (1980) Evidence for uncoupling of the beta receptor-adenylate cyclase complex. Circ Res 47:493\u2013501","journal-title":"Circ Res"},{"key":"9007_CR180","first-page":"60","volume":"223","author":"JD Marsh","year":"1982","unstructured":"Marsh JD, Barry WH, Smith TW (1982) Desensitization to the inotropic effect of isoproterenol in cultured ventricular cells. J Pharmacol Exp Ther 223:60\u201367","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR181","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1476-5381.1993.tb13731.x","volume":"109","author":"DG Wynne","year":"1993","unstructured":"Wynne DG, Poole-Wilson PA, Harding SE (1993) Incomplete reversal of \u03b2-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 109:1071\u20131078","journal-title":"Br J Pharmacol"},{"key":"9007_CR182","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0022-2828(89)90803-1","volume":"21","author":"G Vescovo","year":"1989","unstructured":"Vescovo G, Jones SM, Harding SE et al (1989) Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure. J Mol Cell Cardiol 21:1047\u20131061","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR183","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/cvr\/24.10.834","volume":"24","author":"SM Jones","year":"1990","unstructured":"Jones SM, Kirby MS, Harding SE et al (1990) Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function. Cardiovasc Res 24:834\u2013842","journal-title":"Cardiovasc Res"},{"key":"9007_CR184","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/cvr\/23.10.869","volume":"23","author":"W Vleeming","year":"1989","unstructured":"Vleeming W, van der Wouw PA, Biesebeek JD et al (1989) Density of \u03b2-adrenoceptors in rat heart and lymphocytes 48 hours and 7 days after acute myocardial infarction. Cardiovasc Res 23:859\u2013866","journal-title":"Cardiovasc Res"},{"key":"9007_CR185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0014-2999(90)90045-8","volume":"182","author":"X Lu","year":"1990","unstructured":"Lu X, Barnett DB (1990) Differential rates of down regulation and recovery of rat myocardial \u03b2-adrenoceptor subtypes in vivo. Eur J Pharmacol 182:481\u2013486","journal-title":"Eur J Pharmacol"},{"key":"9007_CR186","doi-asserted-by":"crossref","first-page":"PL171","DOI":"10.1016\/0024-3205(93)90511-Z","volume":"53","author":"H Kimura","year":"1993","unstructured":"Kimura H, Miyamoto A, Ohshika H (1993) Down-regulation of \u03b2-adrenoceptors and loss of Gs\u03b1 subunit levels in ventricular myocardium of rats treated with isoproterenol. Life Sci 53:PL171\u2013176","journal-title":"Life Sci"},{"key":"9007_CR187","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.RES.55.4.524","volume":"55","author":"CJ Limas","year":"1984","unstructured":"Limas CJ, Limas C (1984) Rapid recovery of cardiac \u03b2-adrenergic receptors after isoproterenol-induced \u201cdown\u201d-regulation. Circ Res 55:524\u2013531","journal-title":"Circ Res"},{"key":"9007_CR188","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-198105000-00013","volume":"3","author":"A Bobik","year":"1981","unstructured":"Bobik A, Campbell JH, Carson V et al (1981) Mechanism of isoprenaline-induced refractoriness of the \u03b2-adrenoceptor-adenylate cyclase system in chick embryo cardiac cells. J Cardiovasc Pharmacol 3:541\u2013553","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR189","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1474-8673.1994.tb00622.x","volume":"14","author":"AR Kompa","year":"1994","unstructured":"Kompa AR, Molenaar P, Summers RJ (1994) Effect of chemical sympathectomy on (-)-isoprenaline-induced changes in cardiac \u03b2-adrenoceptor subtypes in the guinea-pig and rat. J Auton Pharmacol 14:411\u2013423","journal-title":"J Auton Pharmacol"},{"key":"9007_CR190","first-page":"393","volume":"255","author":"P Molenaar","year":"1990","unstructured":"Molenaar P, Smolich JJ, Russell FD et al (1990) Differential regulation of beta-1 and beta-2 adrenoceptors in guinea-pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J Pharmacol Exp Ther 255:393\u2013400","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR191","doi-asserted-by":"crossref","first-page":"H1762","DOI":"10.1152\/ajpcell.1996.271.5.C1512","volume":"271","author":"M Zhao","year":"1996","unstructured":"Zhao M, Hagler HK, Muntz KH (1996) Regulation of \u03b11-, \u03b21-, and \u03b22-adrenergic receptors in rat heart by norepinephrine. Am J Physiol 271:H1762\u20131768","journal-title":"Am J Physiol"},{"key":"9007_CR192","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-2999(90)90299-L","volume":"182","author":"MS Elfellah","year":"1990","unstructured":"Elfellah MS, Reid JL (1990) Regulation of \u03b2-adrenoceptors in the guinea-pig left ventricle and skeletal muscle following chronic agonist treatment. Eur J Pharmacol 182:387\u2013392","journal-title":"Eur J Pharmacol"},{"key":"9007_CR193","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.RES.73.5.943","volume":"73","author":"M Zhao","year":"1993","unstructured":"Zhao M, Muntz KH (1993) Differential downregulation of \u03b22-adrenergic receptors in tissue compartments of rat heart is not altered by sympathetic denervation. Circ Res 73:943\u2013951","journal-title":"Circ Res"},{"key":"9007_CR194","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.phrs.2004.10.002","volume":"51","author":"E El-Demerdash","year":"2005","unstructured":"El-Demerdash E, Awad AS, Taha RM et al (2005) Probucol attenuates oxidative stress and energy decline in isoproterenol-induced heart failure in rat. Pharmacol Res 51:311\u2013318","journal-title":"Pharmacol Res"},{"key":"9007_CR195","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.RES.0000045088.59360.B7","volume":"91","author":"K Leineweber","year":"2002","unstructured":"Leineweber K, Brandt K, Wludyka B et al (2002) Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure. Circ Res 91:1056\u20131062","journal-title":"Circ Res"},{"key":"9007_CR196","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00169081","volume":"351","author":"C Schumacher","year":"1995","unstructured":"Schumacher C, Becker H, Conrads R et al (1995) Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 351:398\u2013407","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR197","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cvr\/20.3.221","volume":"20","author":"JS Karliner","year":"1986","unstructured":"Karliner JS, Simpson PC, Honbo N et al (1986) Mechanisms and time course of beta1-adrenoceptor desensitization in mammalian cardiac myocytes. Cardiovasc Res 20:221\u2013228","journal-title":"Cardiovasc Res"},{"key":"9007_CR198","first-page":"675","volume":"223","author":"C Lau","year":"1982","unstructured":"Lau C, Burke S, Slotkin T (1982) Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J Pharmacol Exp Ther 223:675\u2013680","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR199","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF00184292","volume":"343","author":"T Eschenhagen","year":"1991","unstructured":"Eschenhagen T, Mende U, Nose M et al (1991) Isoprenaline-induced increase in mRNA levels of inhibitory G-protein \u03b1-subunits in rat heart. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 343:609\u2013615","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR200","first-page":"773","volume":"42","author":"T Eschenhagen","year":"1992","unstructured":"Eschenhagen T, Mende U, Diederich M et al (1992) Long term \u03b2-adrenoceptor-mediated up-regulation of Gi\u03b1 and G0\u03b1 mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol 42:773\u2013783","journal-title":"Mol Pharmacol"},{"key":"9007_CR201","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00175468","volume":"345","author":"U Mende","year":"1992","unstructured":"Mende U, Eschenhagen T, Geertz B et al (1992) Isoprenaline-induced increase in the 40\/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 345:44\u201350","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9007_CR202","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/01.RES.72.3.696","volume":"72","author":"FU Muller","year":"1993","unstructured":"Muller FU, Boheler KR, Eschenhagen T et al (1993) Isoprenaline stimulates gene transcription of the inhibitory G-protein \u03b1-subunit Gi\u03b12 in rat heart. Circ Res 72:696\u2013700","journal-title":"Circ Res"},{"key":"9007_CR203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0922-4106(89)90051-5","volume":"172","author":"C Reithmann","year":"1989","unstructured":"Reithmann C, Gierschik P, Sidiropoulos D et al (1989) Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein \u03b1-subunits. Eur J Pharmacol 172:211\u2013221","journal-title":"Eur J Pharmacol"},{"key":"9007_CR204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1476-5381.1992.tb14302.x","volume":"106","author":"A Brown","year":"1992","unstructured":"Brown A, Harding SE (1992) Effect of pertussis toxin on \u03b2-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br J Pharmacol 106:115\u2013122","journal-title":"Br J Pharmacol"},{"key":"9007_CR205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(90)94140-S","volume":"191","author":"SM Jones","year":"1990","unstructured":"Jones SM, Hunt NA, Del Monte F et al (1990) Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP. Eur J Pharmacol 191:129\u2013140","journal-title":"Eur J Pharmacol"},{"key":"9007_CR206","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.bjp.0702618","volume":"127","author":"L McMartin","year":"1999","unstructured":"McMartin L, Summers RJ (1999) Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion. Br J Pharmacol 127:1012\u20131020","journal-title":"Br J Pharmacol"},{"key":"9007_CR207","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0304-4165(78)90371-9","volume":"542","author":"J Tse","year":"1978","unstructured":"Tse J, Brackett NL, Kuo JF (1978) Alterations in activities of cyclic nucleotide systems and in \u03b2-adrenergic receptor-mediated activation of cyclic AMP-dependent protein kinase during progression and regression of isoproterenol-induced cardiac hypertrophy. Biochim Biophys Acta 542:399\u2013411","journal-title":"Biochim Biophys Acta"},{"key":"9007_CR208","first-page":"506","volume":"29","author":"SA Harrison","year":"1986","unstructured":"Harrison SA, Reifsnyder DH, Gallis B et al (1986) Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol 29:506\u2013514","journal-title":"Mol Pharmacol"},{"key":"9007_CR209","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1074\/jbc.271.28.16526","volume":"271","author":"C Sette","year":"1996","unstructured":"Sette C, Conti M (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. J Biol Chem 271:16526\u201316534","journal-title":"J Biol Chem"},{"key":"9007_CR210","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/0006-291X(76)90866-4","volume":"73","author":"CV Byus","year":"1976","unstructured":"Byus CV, Chubb JM, Huxtable RJ et al (1976) Increase in type I adenosine 3\u2019, 5\u2019-monophosphate-dependent protein kinase during isoproterenol-induced cardiac hypertrophy. Biochem Biophys Res Commun 73:694\u2013702","journal-title":"Biochem Biophys Res Commun"},{"key":"9007_CR211","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-2828(76)90091-2","volume":"8","author":"DM Horwood","year":"1976","unstructured":"Horwood DM, Singhal RL (1976) Myocardial protein kinases: II. Isoproterenol-induced changes in the activity of soluble and membrane-bound enzymes of rat left ventricle. J Mol Cell Cardiol 8:29\u201338","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR212","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.RES.51.6.787","volume":"51","author":"P Simpson","year":"1982","unstructured":"Simpson P, McGrath A, Savion S (1982) Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51:787\u2013801","journal-title":"Circ Res"},{"key":"9007_CR213","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0735-1097(97)00248-9","volume":"30","author":"M Bohm","year":"1997","unstructured":"Bohm M, Deutsch HJ, Hartmann D et al (1997) Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol 30:992\u2013996","journal-title":"J Am Coll Cardiol"},{"key":"9007_CR214","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0735-1097(02)02134-4","volume":"40","author":"M Metra","year":"2002","unstructured":"Metra M, Nodari S, D\u2019Aloia A et al (2002) Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure. J Am Coll Cardiol 40:1248\u20131258","journal-title":"J Am Coll Cardiol"},{"key":"9007_CR215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.RES.54.3.286","volume":"54","author":"KM Baker","year":"1984","unstructured":"Baker KM, Campanile CP, Trachte GJ et al (1984) Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res 54:286\u2013293","journal-title":"Circ Res"},{"key":"9007_CR216","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0022-2828(90)90086-H","volume":"22","author":"AM Katz","year":"1990","unstructured":"Katz AM (1990) Angiotensin II: hemodynamic regulator or growth factor? J Mol Cell Cardiol 22:739\u2013747","journal-title":"J Mol Cell Cardiol"},{"key":"9007_CR217","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.68.4.905","volume":"68","author":"K Lindpaintner","year":"1991","unstructured":"Lindpaintner K, Ganten D (1991) The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 68:905\u2013921","journal-title":"Circ Res"},{"key":"9007_CR218","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.RES.72.6.1245","volume":"72","author":"W Schorb","year":"1993","unstructured":"Schorb W, Booz GW, Dostal DE et al (1993) Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72:1245\u20131254","journal-title":"Circ Res"},{"key":"9007_CR219","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.91.5.1461","volume":"91","author":"V Regitz-Zagrosek","year":"1995","unstructured":"Regitz-Zagrosek V, Friedel N, Heymann A et al (1995) Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91:1461\u20131471","journal-title":"Circulation"},{"key":"9007_CR220","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.RES.74.4.727","volume":"74","author":"DC Crawford","year":"1994","unstructured":"Crawford DC, Chobanian AV, Brecher P (1994) Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 74:727\u2013739","journal-title":"Circ Res"},{"key":"9007_CR221","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","volume":"73","author":"J Sadoshima","year":"1993","unstructured":"Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res 73:413\u2013423","journal-title":"Circ Res"},{"key":"9007_CR222","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ajh\/5.5.276","volume":"5","author":"DE Dostal","year":"1992","unstructured":"Dostal DE, Baker KM (1992) Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Am J Hypertens 5:276\u2013280","journal-title":"Am J Hypertens"},{"key":"9007_CR223","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.HYP.19.6.708","volume":"19","author":"M Nagano","year":"1992","unstructured":"Nagano M, Higaki J, Nakamura F et al (1992) Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension 19:708\u2013712","journal-title":"Hypertension"},{"key":"9007_CR224","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1124\/jpet.103.063388","volume":"309","author":"R Bos","year":"2004","unstructured":"Bos R, Mougenot N, Mediani O et al (2004) Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat. J Pharmacol Exp Ther 309:1160\u20131166","journal-title":"J Pharmacol Exp Ther"},{"key":"9007_CR225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2005.07.026","volume":"520","author":"EM Oliveira","year":"2005","unstructured":"Oliveira EM, Krieger JE (2005) Chronic \u03b2-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol 520:135\u2013141","journal-title":"Eur J Pharmacol"},{"key":"9007_CR226","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.fjc.0000175234.95831.3e","volume":"46","author":"AS Galvez","year":"2005","unstructured":"Galvez AS, Fiedler JL, Ocaranza MP et al (2005) Perindopril regulates \u03b2-agonist-induced cardiac apoptosis. J Cardiovasc Pharmacol 46:255\u2013261","journal-title":"J Cardiovasc Pharmacol"},{"key":"9007_CR227","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.HYP.26.6.971","volume":"26","author":"V Robert","year":"1995","unstructured":"Robert V, Silvestre JS, Charlemagne D et al (1995) Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971\u2013978","journal-title":"Hypertension"},{"key":"9007_CR228","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/01.RES.37.3.318","volume":"37","author":"MH Weinberger","year":"1975","unstructured":"Weinberger MH, Aoi W, Henry DP (1975) Direct effect of beta-adrenergic stimulation on renin release by the rat kidney slice in vitro. Circ Res 37:318\u2013324","journal-title":"Circ Res"},{"key":"9007_CR229","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s003950070025","volume":"95","author":"DE Dostal","year":"2000","unstructured":"Dostal DE, Booz GW, Baker KM (2000) Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and \u03b2-adrenergic stimulation. Basic Res Cardiol 95:485\u2013490","journal-title":"Basic Res Cardiol"},{"key":"9007_CR230","first-page":"H2263","volume":"284","author":"JC Borges","year":"2003","unstructured":"Borges JC, Silva JA, Gomes MA et al (2003) Tonin in rat heart with experimental hypertrophy. Am J Physiol 284:H2263\u20132268","journal-title":"Am J Physiol"},{"key":"9007_CR231","first-page":"H144","volume":"250","author":"M Nakamuru","year":"1986","unstructured":"Nakamuru M, Jackson EK, Inagami T (1986) \u03b2-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol 250:H144\u2013148","journal-title":"Am J Physiol"},{"key":"9007_CR232","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.CIR.0000092166.30360.78","volume":"108","author":"L Barki-Harrington","year":"2003","unstructured":"Barki-Harrington L, Luttrell LM, Rockman HA (2003) Dual inhibition of \u03b2-adrenergic and angiotensin II receptors by a single antagonist. A functional role for receptor-receptor interaction in vivo. Circulation 108:1611\u20131618","journal-title":"Circulation"},{"key":"9007_CR233","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1172\/JCI117706","volume":"95","author":"RL Duerr","year":"1995","unstructured":"Duerr RL, Huang S, Miraliakbar HR et al (1995) Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95:619\u2013627","journal-title":"J Clin Invest"},{"key":"9007_CR234","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/01.CIR.93.12.2188","volume":"93","author":"RL Duerr","year":"1996","unstructured":"Duerr RL, McKirnan MD, Gim RD et al (1996) Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93:2188\u20132196","journal-title":"Circulation"},{"key":"9007_CR235","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.CIR.87.5.1715","volume":"87","author":"H Ito","year":"1993","unstructured":"Ito H, Hiroe M, Hirata Y et al (1993) Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 87:1715\u20131721","journal-title":"Circulation"},{"key":"9007_CR236","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0008-6363(97)00210-1","volume":"37","author":"XW Sun","year":"1998","unstructured":"Sun XW, Ng YC (1998) Effects of norepinephrine on expression of IGF-1\/IGF-1R and SERCA2 in rat heart. Cardiovasc Res 37:202\u2013209","journal-title":"Cardiovasc Res"},{"key":"9007_CR237","doi-asserted-by":"crossref","first-page":"C910","DOI":"10.1152\/ajpcell.1995.268.4.C910","volume":"268","author":"SA Fisher","year":"1995","unstructured":"Fisher SA, Absher M (1995) Norepinephrine and angiotensin II stimulate secretion of TGF-\u03b2 by neonatal rat cardiac fibroblasts in vitro. Am J Physiol 268:C910\u2013917","journal-title":"Am J Physiol"},{"key":"9007_CR238","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI117485","volume":"94","author":"N Takahashi","year":"1994","unstructured":"Takahashi N, Calderone A, Izzo NJ et al (1994) Hypertrophic stimuli induce transforming growth factor-\u03b21 expression in rat ventricular myocytes. J Clin Invest 94:1470\u20131476","journal-title":"J Clin Invest"},{"key":"9007_CR239","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.HYP.0000141414.87026.4d","volume":"44","author":"W Briest","year":"2004","unstructured":"Briest W, Homagk L, Rabler B et al (2004) Norepinephrine-induced changes in cardiac transforming growth factor-\u03b2 isoform expression pattern of female and male rats. Hypertension 44:410\u2013418","journal-title":"Hypertension"},{"key":"9007_CR240","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s001090050176","volume":"75","author":"HG Zimmer","year":"1997","unstructured":"Zimmer HG (1997) Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med 75:849\u2013859","journal-title":"J Mol Med"},{"key":"9007_CR241","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02190548","volume":"86","author":"RD Hannan","year":"1991","unstructured":"Hannan RD, West AK (1991) Adrenergic agents, but not triiodo-L-thyronine induce c-fos and c-myc expression in the rat heart. Basic Res Cardiol 86:154\u2013164","journal-title":"Basic Res Cardiol"},{"key":"9007_CR242","doi-asserted-by":"crossref","first-page":"25535","DOI":"10.1016\/S0021-9258(19)74073-3","volume":"267","author":"NH Bishopric","year":"1992","unstructured":"Bishopric NH, Jayasena V, Webster KA (1992) Positive regulation of the skeletal \u03b1-actin gene by Fos and Jun in cardiac myocytes. J Biol Chem 267:25535\u201325540","journal-title":"J Biol Chem"},{"key":"9007_CR243","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1016\/S0021-9258(18)77420-6","volume":"265","author":"K Iwaki","year":"1990","unstructured":"Iwaki K, Sukhatme V, Shubeita HE et al (1990) \u03b1- and \u03b2-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem 265:13809\u201313817","journal-title":"J Biol Chem"},{"key":"9007_CR244","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1074\/jbc.274.14.9760","volume":"274","author":"Y Zou","year":"1999","unstructured":"Zou Y, Komuro I, Yamazaki T et al (1999) Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. J Biol Chem 274:9760\u20139770","journal-title":"J Biol Chem"},{"key":"9007_CR245","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/01.CIR.101.20.2338","volume":"101","author":"DR Murray","year":"2000","unstructured":"Murray DR, Prabhu SD, Chandrasekar B (2000) Chronic \u03b2-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101:2338\u20132341","journal-title":"Circulation"},{"key":"9007_CR246","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/phrs.1998.0365","volume":"38","author":"N Rathore","year":"1998","unstructured":"Rathore N, John S, Kale M et al (1998) Lipid peroxidation and antioxidant enzymes in isoproterenol-induced oxidative stress in rat tissues. Pharmacol Res 38:297\u2013303","journal-title":"Pharmacol Res"},{"key":"9007_CR247","first-page":"1251","volume":"50","author":"O Ondrejickova","year":"1991","unstructured":"Ondrejickova O, Dzurba A, Sedlak J et al (1991) Processes linked to the formation of reactive oxygen species are not necessarily involved in the development of isoproterenol-induced hypertrophy of the heart. The effect of stobadine. Biomed Biochim Acta 50:1251\u20131254","journal-title":"Biomed Biochim Acta"},{"key":"9007_CR248","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1007176030884","volume":"212","author":"FU Muller","year":"2000","unstructured":"Muller FU, Neumann J, Schmitz W (2000) Transcriptional regulation by cAMP in the heart. Mol Cell Biochem 212:11\u201317","journal-title":"Mol Cell Biochem"},{"key":"9007_CR249","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/01.CIR.92.8.2041","volume":"92","author":"FU Muller","year":"1995","unstructured":"Muller FU, Boknik P, Horst A et al (1995) cAMP response element binding protein is expressed and phosphorylated in the human heart. Circulation 92:2041\u20132043","journal-title":"Circulation"},{"key":"9007_CR250","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s004410050653","volume":"285","author":"PH Goldspink","year":"1996","unstructured":"Goldspink PH, Russell B (1996) Physiological role of phosphorylation of the cyclic AMP response element binding protein in rat cardiac nuclei. Cell Tissue Res 285:379\u2013385","journal-title":"Cell Tissue Res"},{"key":"9007_CR251","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.RES.74.6.1042","volume":"74","author":"PH Goldspink","year":"1994","unstructured":"Goldspink PH, Russel B (1994) The cAMP response element binding protein is expressed and phosphorylated in cardiac myocytes. Circ Res 74:1042\u20131049","journal-title":"Circ Res"},{"key":"9007_CR252","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0008-6363(01)00361-3","volume":"52","author":"FU Muller","year":"2001","unstructured":"Muller FU, Boknik P, Knapp J et al (2001) Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes. Cardiovasc Res 52:95\u2013102","journal-title":"Cardiovasc Res"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-007-9007-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9007-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-007-9007-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:52:18Z","timestamp":1736923938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-007-9007-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":252,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9007"],"URL":"https:\/\/doi.org\/10.1007\/s10741-007-9007-4","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"14 February 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}